Valeant Pharmaceuticals receives default noticeStaff writer ▼ | June 3, 2016
Lenders warned Valeant Pharmaceuticals that it has defaulted on certain debts after failing to submit a public filing, giving the embattled drugmaker two months to rectify the matter.
Pharmaceuticals Valeant said that it had received a warning
Loan terms give the company 60 days from the time it received the notice, which occurred Thursday, to file the 10-Q. Valeant reiterated a previous statement that it will file the form on or before June 10. ■